Regulation of stem cell factor expression in inflammation and asthma-Reference-Cited by-同舟云学术

Regulation of stem cell factor expression in inflammation and asthma

Published:2005-03 Issue:suppl 1 Volume:100 Page:145-151
ISSN:0074-0276
Container-title:Memórias do Instituto Oswaldo Cruz
language:
Short-container-title:Mem. Inst. Oswaldo Cruz

Author:

Da Silva Carla A¹,Frossard Nelly¹

Affiliation:

1. Université Louis Pasteur, France

Publisher

FapUNIFESP (SciELO)

Subject

Microbiology (medical)

Link

http://www.scielo.br/pdf/mioc/v100s1/v100ns1a24.pdf

Reference74 articles.

1. Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts;Adachi S;Blood,1992

2. Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor;Adachi S;Exp Hematol,1995

3. Glucocorticoid-regulated transcription factors;Adcock IM;Pulm Pharmacol Ther,2001

4. The expression of stem cell factor and c-kit receptor in human asthmatic airways;Al-Muhsen SZ;Clin Exp Allergy,2004

5. Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24;Anderson DM;Cell Growth Differ,1991

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone Marrow-Derived C-Kit+ Cells Improved Inflammatory IL-33/ST-2/ILC2 Axis in the Lung Tissue of Type 2 Diabetic Rats;Applied Biochemistry and Biotechnology;2024-03-13

2. Bone marrow-derived C-kit⁺ cells improved inflammatory IL-33/ST-2/ILC2 axis in the lung tissue of type 2 diabetic rats;2023-12-28

3. Lung Function in African American Children with Asthma Is Associated with Novel Regulatory Variants of the KIT Ligand KITLG/SCF and Gene-By-Air-Pollution Interaction;Genetics;2020-07-01

4. Novel KITLG/SCF regulatory variants are associated with lung function in African American children with asthma;2020-02-23

5. Serum level of stem cell factor and its soluble receptor in aspirin-exacerbated respiratory disease;Immunotherapy;2019-10